XPO Reports Strong Q4 2025 Adjusted Results, Provides Positive 2026 Outlook and LTL Growth Targets
summarizeSummary
XPO reported robust Q4 2025 adjusted financial results and issued positive 2026 guidance, emphasizing strong LTL segment performance and long-term growth strategies.
check_boxKey Events
-
Q4 2025 Adjusted Performance
Adjusted EBITDA increased 11% year-over-year, and adjusted diluted EPS rose 18% year-over-year, indicating strong operational health despite a GAAP EPS decline due to non-recurring items.
-
LTL Segment Strength
North American LTL adjusted operating income grew 14% year-over-year, with the adjusted operating ratio improving by 180 basis points to 84.4%.
-
2026 Planning Assumptions
The company provided full-year 2026 guidance, including gross capex of $500 million to $600 million, interest expense of $205 million to $215 million, and an adjusted effective tax rate of 24% to 25%.
-
Long-Term LTL Targets
XPO outlined ambitious targets for 2021-2027, including a North American LTL revenue CAGR of 6%-8% and adjusted EBITDA CAGR of 11%-13%, alongside at least 600 basis points of adjusted operating ratio improvement.
auto_awesomeAnalysis
XPO, Inc. filed an investor presentation detailing its strong operational performance for Q4 2025, with adjusted EBITDA up 11% and adjusted diluted EPS up 18% year-over-year. This filing, concurrent with a prior disclosure of Q4 results, provides comprehensive context, including detailed segment performance, strategic initiatives, and crucial 2026 planning assumptions. The company also outlined ambitious long-term LTL growth targets through 2027, aiming for significant revenue and adjusted EBITDA CAGR, alongside substantial operating ratio improvement. These details reinforce the company's strategic direction and operational efficiency, supporting investor confidence as the stock trades near its 52-week high.
At the time of this filing, XPO was trading at $177.00 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $21.1B. The 52-week trading range was $85.06 to $180.39. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.